Home
关于我们
产品中心
新闻资讯
技术文章
定制合成
联系我们
中文
产品中心
PRODUCTS
Current location:
Home
>>
产品中心
>>
抗体
PRODUCT CLASSIFICATION
News
NEWS
Application of bioactive small molecules in disease research
Green intelligence creates industry trends, Fuzhen Biology promotes low-carbon development of fine chemical industry
The monoclonal antibody industry is developing rapidly, and Fuzhen Biotechnology is improving its supply system for monoclonal antibody related raw materials
The global biopharmaceutical market continues to expand
Molecular building blocks are used as accelerators for the development of new drugs
Structural formula
Art.No.
Name
CAS
Pureness
CFZ03019
Ianalumab
1929549-92-7
95%
CFZ03018
Gilvetmab
1808081-43-7
95%
CFZ03017
Azintuxizumab
1826819-57-1
95%
CFZ03016
Research Grade Iladatuzumab
1906205-76-2
95%
CFZ03015
Larcaviximab
1792982-56-9
95%
CFZ03014
Selicrelumab
1622140-49-1
95%
CFZ03013
Research Grade Prasinezumab
1960462-19-4
95%
CFZ03012
alacotuzumab
1826831-79-1
95%
CFZ03011
Tomuzotuximab
1646321-00-7
95%
CFZ03010
Research Grade Ladiratuzumab
1629760-28-6
95%
Home
<<
···
12
13
14
15
16
···
14/59
>>
Last
QQ
QQ
Service Hotline:
15111215862
18229892877